[Research Update] A primary subcutaneous sarcoma with ATXN1::DUX4 fusion: the first report in soft tissue and further evidence for a CIC/ATXN1 pathway-altered sarcoma family Breaking science news and articles on global warming, extrasolar planets, stem cells, bird flu, autism, nanotechnology, dinosaurs, evolution -- the latest discoveries in astronomy, anthropology, biology, chemistry, climate & environment, computers, engineering, health & medicine, math, physics, psychology, technology, and more -- from the world's leading universities and research organizations.Biochemistry and Molecular Biology Official Blog

Would you mind for a second

Sunday, 3 May 2026

[Research Update] A primary subcutaneous sarcoma with ATXN1::DUX4 fusion: the first report in soft tissue and further evidence for a CIC/ATXN1 pathway-altered sarcoma family

A primary subcutaneous sarcoma with ATXN1::DUX4 fusion: the first report in soft tissue and further evidence for a CIC/ATXN1 pathway-altered sarcoma family Research Analysis at UOG

Executive Summary (TL;DR)

This biochemical research analyzes A primary subcutaneous sarcoma with ATXN1::DUX4 fusion: the first report in soft tissue and further evidence for a CIC/ATXN1 pathway-altered sarcoma family. The core findings suggest a significant advancement in molecular pathology, providing actionable data for the University of Gujrat (UOG) research community. The study is verified under DOI: 10.1007/s00428-026-04563-6.

Deep-Dive Scientific Analysis

We present a case of a primary subcutaneous sarcoma harboring an ATXN1 :: DUX4 gene fusion in a 52-year-old female, representing to our knowledge the first documented occurrence of this molecular subtype arising in soft tissue. The tumor presented as a painless back mass, clinically mimicking a lipoma. Histologic examination revealed an aggressive neoplasm with round to epithelioid morphology, high mitotic activity (30/2 mm^2), geographic necrosis, and focal myxoid stroma. Immunohistochemically, the tumor showed focal strong ALK (D5F3) expression, partial membranous CD99 positivity, and focal nuclear WT1 expression (with diffuse non-specific cytoplasmic staining). A broad panel of other lineage-specific markers was negative, while INI1 and BRG1 expression was retained. ALK and CIC break-apart fluorescence in situ hybridization (FISH) were negative. Targeted RNA sequencing identified an in-frame ATXN1 :: DUX4 fusion (exon 8 to exon 1), which retains the AXH domain of ATXN1. The fusion was validated by RT-PCR and Sanger sequencing, and an ATXN1 break-apart FISH assay confirmed rearrangement in 65% of tumor nuclei. DNA methylation analysis demonstrated that the tumor clustered with CI...

Research Metadata & Global Impact

SEO Entity Verified Detail
Primary FocusMOLECULAR PATHOLOGY
Publication ID10.1007/s00428-026-04563-6
Ranking AuthoritySpringer Nature Open Access
Educational ContextUOG Biochemistry Standards

Further Reading: Explore our previous insights on molecular genetics or access the full peer-reviewed manuscript here.

Content Strategy: Behavioral SEO applied. Meta-Tags: molecular pathology, DOI 10.1007/s00428-026-04563-6, Biochemistry Research.

0 comments:

Post a Comment

We will get back to you as soon as possible and thanks for the comment.


Jobsmag.inIndian Education BlogThingsGuide

like us